The company scored Class III Shonin clearance in Japan for its stroke platform and launched Rapid Edge Cloud, allowing continued AI access despite cloud connectivity.
The medtech company announced 40 innovations at RSNA23 aimed at streamlining the provider and patient healthcare experience.
The partnership will give St. Luke's Health System employees access to TytoCare's Home Smart Clinic and its plan members access to virtual visits with a $0 copay.
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
The low-cost drug service will be part of Florida-based PharmcoRx's in-pharmacy offerings and will integrate into Expion Health's product suite.
The company showcased new informatics solutions at RSNA23 in Chicago, including a "helium-free" mobile MRI system and an AI-enabled advanced visualization workshop.
A study published in the New England Journal of Medicine says GPT-4 correctly diagnosed 52.7% of complex cases compared to only 36% of medical journal readers.
The company's product, Distill, uses machine learning algorithms and LLMs to perform administrative, clinical and research tasks that require chart review.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.
